PUMA BIOTECHNOLOGY, INC. Property, Plant and Equipment, Gross
PUMA BIOTECHNOLOGY, INC. (PBYI) had Property, Plant and Equipment, Gross of $3.01 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $3.01M.
- 2026-03-31: Property, Plant and Equipment, Gross $3.01M.
- 2025-12-31: Property, Plant and Equipment, Gross $4.79M.
- 2025-09-30: Property, Plant and Equipment, Gross $6.89M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $3.01M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.01M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.79M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $6.89M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $8.46M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $8.44M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $8.38M 10-K · filed 2026-02-26 |
| 2024-09-30 | $8.58M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $8.56M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $8.54M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $8.54M 10-K · filed 2025-02-27 |
| 2023-09-30 | $8.67M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $8.64M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $8.57M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $8.57M 10-K · filed 2024-02-29 |
| 2022-09-30 | $8.57M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $8.57M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $8.57M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $8.62M 10-K · filed 2023-03-02 |
| 2021-09-30 | $8.63M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $8.63M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $8.63M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.63M 10-K · filed 2022-03-03 |
| 2020-09-30 | $8.69M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.18M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $9.18M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $9.16M 10-K · filed 2021-03-01 |
| 2019-09-30 | $8.83M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $8.87M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $9.14M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $9.14M 10-K · filed 2020-02-28 |
| 2018-09-30 | $9.14M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $8.93M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $8.65M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $8.53M 10-K · filed 2019-03-01 |
| 2017-09-30 | $8.49M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $8.39M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $8.23M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $8.10M 10-K · filed 2018-03-09 |
| 2016-09-30 | $7.85M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $7.61M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $4.53M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $4.48M 10-K · filed 2017-03-01 |
| 2015-09-30 | $4.42M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $4.27M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $3.92M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $3.48M 10-K · filed 2016-02-29 |
| 2014-09-30 | $3.05M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $2.92M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $2.60M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $2.38M 10-K · filed 2015-03-02 |
| 2013-09-30 | $2.19M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $2.11M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $1.94M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $1.75M 10-K · filed 2014-03-03 |
| 2011-12-31 | $693.00K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |